Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue

Authors :: Régis Costello
J Colle
Raphael Cauchois
Gilles Kaplanski
Pierre-André Jarrot
Anne-Laure Couderc
Julie Lachamp
Rodolphe Jean
Antoine Tichadou
Geoffroy Venton
Arthur Boyer
Robin Arcani
Laure Farnault
Marie Koubi
Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN)
Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Hôpital de la Conception [CHU - APHM] (LA CONCEPTION)
Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )
Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES)
Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS)
RANCHON, GUILLAUME
Source :: Annals of Hematology, Annals of Hematology, 2021, 100 (11), pp.2799-2803. ⟨10.1007/s00277-021-04656-z⟩
Publication Year :: 2021
Publisher :: Springer Science and Business Media LLC, 2021.
Abstract: Specificities of COVID-19 disease course in patients with haematologic malignancies are still poorly studied. So, we aimed to compare patients with haematologic malignancies to patients without malignancies, matched by sex and age and hospitalised for COVID-19 at the same time and in the same centre. Among 25 patients with haematologic malignancies, we found that mortality (40% versus 4%, p

Tools